Raghuvir Synthetics [RAGHUSYN] vs Raymond [RAYMOND] Detailed Stock Comparison
Raghuvir Synthetics
BSE
Loading...
Raymond
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Raghuvir Synthetics wins in 9 metrics, Raymond wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Raghuvir Synthetics | Raymond | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 38.44 | 95.27 | Raghuvir Synthetics |
| Price-to-Book Ratio | 13.96 | 1.11 | Raymond |
| Debt-to-Equity Ratio | 102.48 | 17.81 | Raymond |
| PEG Ratio | N/A | -3.44 | N/A |
| EV/EBITDA | 21.54 | 26.11 | Raghuvir Synthetics |
| Profit Margin (TTM) | 3.77% | 271.84% | Raymond |
| Operating Margin (TTM) | 5.88% | 3.39% | Raghuvir Synthetics |
| EBITDA Margin (TTM) | 5.88% | 3.39% | Raghuvir Synthetics |
| Return on Equity | 25.70% | 183.56% | Raymond |
| Return on Assets (TTM) | 7.17% | 98.90% | Raymond |
| Free Cash Flow (TTM) | $100.88M | $752.80M | Raymond |
| 1-Year Return | 0.48% | -69.88% | Raghuvir Synthetics |
| Price-to-Sales Ratio (TTM) | 1.45 | 2.01 | Raghuvir Synthetics |
| Enterprise Value | $5.20B | $46.33B | Raymond |
| EV/Revenue Ratio | 1.53 | 2.25 | Raghuvir Synthetics |
| Gross Profit Margin (TTM) | 21.47% | 40.59% | Raymond |
| Revenue per Share (TTM) | $88 | $0 | Raghuvir Synthetics |
| Earnings per Share (Diluted) | $3.30 | $6.52 | Raymond |
| Beta (Stock Volatility) | -0.89 | -0.02 | Raghuvir Synthetics |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Raghuvir Synthetics vs Raymond Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Raghuvir Synthetics | -0.08% | -0.55% | 0.59% | 1.20% | -7.04% | -25.14% |
| Raymond | -1.87% | 1.45% | -13.98% | -6.50% | -55.41% | -63.33% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Raghuvir Synthetics | 0.48% | -26.06% | -49.26% | 225.26% | 375.09% | 2,687.91% |
| Raymond | -69.88% | -35.65% | 103.96% | 55.89% | 63.14% | 70.51% |
Performance & Financial Health Analysis: Raghuvir Synthetics vs Raymond
| Metric | RAGHUSYN | RAYMOND |
|---|---|---|
| Market Information | ||
| Market Cap | ₹4.92B | ₹41.39B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,129 | 565,729 |
| 90 Day Avg. Volume | 4,426 | 651,873 |
| Last Close | ₹126.85 | ₹621.15 |
| 52 Week Range | ₹115.00 - ₹314.30 | ₹523.10 - ₹2,182.00 |
| % from 52W High | -59.64% | -71.53% |
| All-Time High | ₹1,026.50 (Dec 27, 2021) | ₹3,496.00 (Jul 08, 2024) |
| % from All-Time High | -87.64% | -82.23% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | -0.44% |
| Quarterly Earnings Growth | 7.34% | -0.28% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 2.72% |
| Operating Margin (TTM) | 0.06% | 0.03% |
| Return on Equity (TTM) | 0.26% | 1.84% |
| Debt to Equity (MRQ) | 102.48 | 17.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹9.09 | ₹558.44 |
| Cash per Share (MRQ) | ₹2.60 | ₹114.41 |
| Operating Cash Flow (TTM) | ₹6.77M | ₹69.27B |
| Levered Free Cash Flow (TTM) | ₹90.25M | ₹76.31B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Raghuvir Synthetics vs Raymond
| Metric | RAGHUSYN | RAYMOND |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 38.44 | 95.27 |
| Forward P/E | N/A | 4.79 |
| PEG Ratio | N/A | -3.44 |
| Price to Sales (TTM) | 1.45 | 2.01 |
| Price to Book (MRQ) | 13.96 | 1.11 |
| Market Capitalization | ||
| Market Capitalization | ₹4.92B | ₹41.39B |
| Enterprise Value | ₹5.20B | ₹46.33B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.53 | 2.25 |
| Enterprise to EBITDA | 21.54 | 26.11 |
| Risk & Other Metrics | ||
| Beta | -0.89 | -0.02 |
| Book Value per Share (MRQ) | ₹9.09 | ₹558.44 |
Financial Statements Comparison: Raghuvir Synthetics vs Raymond
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RAGHUSYN | RAYMOND |
|---|---|---|
| Revenue/Sales | ₹900.08M | ₹5.24B |
| Cost of Goods Sold | ₹706.86M | ₹3.11B |
| Gross Profit | ₹193.22M | ₹2.13B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹38.37M | ₹177.70M |
| EBITDA | ₹67.04M | ₹852.70M |
| Pre-Tax Income | ₹39.31M | ₹282.10M |
| Income Tax | ₹-1.66M | ₹75.90M |
| Net Income (Profit) | ₹40.97M | ₹53.28B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RAGHUSYN | RAYMOND |
|---|---|---|
| Cash & Equivalents | ₹82.65M | ₹343.70M |
| Total Current Assets | ₹533.98M | ₹52.03B |
| Total Current Liabilities | ₹604.49M | ₹30.16B |
| Long-Term Debt | ₹286.26M | ₹3.45B |
| Total Shareholders Equity | ₹351.15M | ₹41.58B |
| Retained Earnings | N/A | ₹18.59B |
| Property, Plant & Equipment | ₹633.50M | ₹8.90B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RAGHUSYN | RAYMOND |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | RAGHUSYN | RAYMOND |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 3,129 | 565,729 |
| Average Daily Volume (90 Day) | 4,426 | 651,873 |
| Shares Outstanding | 38.75M | 66.55M |
| Float Shares | 8.29M | 31.00M |
| % Held by Insiders | 0.82% | 0.52% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Raghuvir Synthetics vs Raymond
| Metric | RAGHUSYN | RAYMOND |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | ₹5.33 |
| 3-Year Avg Dividend Yield | N/A | 0.31% |
| 3-Year Total Dividends | N/A | ₹16.00 |
| Ex-Dividend Date | N/A | Jun 13, 2024 |